Literature DB >> 1553818

Immunoglobulin idiotype expression in reactive lymphoid tissues and B-cell lymphomas.

M Shiota1, K Kitamura, M Noda, Y Kawanishi, S Hart, R A Miller, S Mori.   

Abstract

In an investigation of the immunoglobulin idiotypic expression of non-tumour and neoplastic B lymphocytes in situ, fresh-frozen specimens of reactive tonsils, lymph nodes and B-cell malignant lymphomas (B-MLs) from Japanese patients were studied immunohistochemically with 39 different anti-idiotype antibodies. In reactive lymphoid tissues, while idiotype-bearing cells were largely distributed sparsely in follicles and perifollicular areas, some were heavily crowded in particular germinal centres (GCs), suggesting the presence of oligoclonal proliferations of B-cells in GCs. Forty-eight out of 100 B-MLs reacted with anti-idiotype antibodies. This proportion was significantly higher than those reported in Western cases (27-36%), indicating that Japanese B-MLs share public idiotypes much frequently than western cases. The idiotypes demonstrated in these lymphomas, in contrast to those not expressed in any B-ML, were found much commonly in non-tumour lymphocytes, suggesting that such public idiotypes as were common in B-MLs were frequently shared by normal B-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553818     DOI: 10.1007/bf01600279

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  25 in total

Review 1.  Antiidiotype antibody therapy of B-cell lymphoma.

Authors:  S L Brown; R A Miller; R Levy
Journal:  Semin Oncol       Date:  1989-06       Impact factor: 4.929

2.  Cytogenetic abnormalities in benign lymphoid hyperplasia: a dual-parameter study using chromosome analysis and flow cytometry.

Authors:  J Grace; B E Hall; M Lew; S Singh; S Pittman; A A Palmer; R Zbroja; J Wass; P C Vincent
Journal:  Int J Cancer       Date:  1989-12-15       Impact factor: 7.396

3.  Evolving abundance and clonal pattern of human germinal center B cells during childhood.

Authors:  Y Valles-Ayoub; H L Govan; J Braun
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

Review 4.  The current status of monoclonal antibodies in the diagnosis and therapy of cancer.

Authors:  J N Lowder
Journal:  Curr Probl Cancer       Date:  1986-10       Impact factor: 3.187

5.  Shared idiotypes expressed by human B-cell lymphomas.

Authors:  R A Miller; S Hart; M Samoszuk; C Coulter; S Brown; D Czerwinski; J Kelkenberg; I Royston; R Levy
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

6.  Screening for anti-idiotypic monoclonal antibodies on paraformaldehyde-fixed lymphoma cells.

Authors:  M Samoszuk; S Sholly; A L Epstein
Journal:  Hybridoma       Date:  1987-12

7.  Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type.

Authors:  T Suchi; K Tajima; K Nanba; H Wakasa; A Mikata; M Kikuchi; S Mori; S Watanabe; N Mohri; M Shamoto; K Harigaya; T Itagaki; M Matsuda; Y Kirino; K Takagi; S Fukunaga
Journal:  Acta Pathol Jpn       Date:  1979-09

8.  Retention of an idiotypic determinant in a human B-cell lymphoma undergoing immunoglobulin variable-region mutation.

Authors:  S Kon; S Levy; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue.

Authors:  M Naiem; J Gerdes; Z Abdulaziz; H Stein; D Y Mason
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

Review 10.  Monoclonal antibodies--therapeutic and diagnostic uses in malignancy.

Authors:  J N Lowder; R Levy
Journal:  West J Med       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.